Novacyt S.A. (LON:NCYT – Get Free Report) rose 16% during trading on Wednesday . The stock traded as high as GBX 58 ($0.74) and last traded at GBX 58 ($0.74). Approximately 849,279 shares were traded during mid-day trading, an increase of 62% from the average daily volume of 522,714 shares. The stock had previously closed at GBX 50 ($0.63).
Novacyt Price Performance
The company has a quick ratio of 4.46, a current ratio of 4.04 and a debt-to-equity ratio of 18.67. The company has a market capitalization of £39.55 million, a price-to-earnings ratio of -110.38 and a beta of -1.86. The stock’s 50-day simple moving average is GBX 53.11 and its two-hundred day simple moving average is GBX 58.40.
Novacyt Company Profile
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Featured Stories
- Five stocks we like better than Novacyt
- Using the MarketBeat Stock Split Calculator
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is the S&P 500 and How It is Distinct from Other Indexes
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- ETF Screener: Uses and Step-by-Step Guide
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.
